4
Changes in Ownership
CAPRICOR THERAPEUTICS, INC. Filed Acc 0001873796-26-000004
Director sold 115,000 shares at an average $30.57 ($3,515,468)
- Director acquired 115,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sabar Karimah Es Director | 2026-03-31 | Option exercise 10b5-1 | +61,265 | $4.86 | $297,748 | 61,265 | D |
| Sabar Karimah Es Director | 2026-03-31 | Sale 10b5-1 | −61,265 | $30.17 | $1,848,243 | 0 | D |
| Sabar Karimah Es Director | 2026-04-01 | Option exercise 10b5-1 | +53,735 | $4.86 | $261,152 | 53,735 | D |
| Sabar Karimah Es Director | 2026-04-01 | Sale 10b5-1 | −53,735 | $31.03 | $1,667,225 | 0 | D |
| Derivatives | |||||||
| Sabar Karimah Es Director | 2026-03-31 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −61,265 | 53,735 | D | ||
| Sabar Karimah Es Director | 2026-04-01 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −53,735 | 0 | D | ||
| Open-market sales · 115,000 sh · avg $30.57 · $3,515,468 | |||||||
Loading xslF345X06/form4-04012026_080408.xml…